#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Mastocytosis Hepatoblastoma Hepato-lenticular degeneration Pleomorphic liposarcoma Hypersensitivity pneumonitis Depression Intracranial calcification Malignant oligodendroglioma Chronic cutaneous lupus erythematosus Ovarian epithelial cancer Anti-myelin-associated glycoprotein antibodies positive Malignant melanoma Friedreich's ataxia Angiosarcoma non-metastatic Osteomyelitis More trials…

    Learn about Rare Diseases

    Biotinidase deficiency – Diagnostics Primary mediastinal large B-cell lymphoma – Diagnostics Factor VIII deficiency Nodal marginal zone B-cell lymphoma – Trials in Disease Sarcoidosis – Life with Disease Haemophagocytic lymphohistiocytosis Congenital nephrogenic diabetes insipidus – Trials in Disease Nephrotic syndrome – Trials in Disease Factor IX deficiency – Trials in Disease Pulmonary fibrosis – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    L-SERINE Elexacaftor Ademetionine Palonosetron Hydrochloride Acetazolamide Sodium Sodium Butyrate Iclepertin Omp10 Medi0618 Iomeprol Ambrisentan Lumasiran Fostemsavir Cytisine Insulin Human (Rdna) Ruxotemitide AZD5335 SOVATELTIDE L-Arginine Hydrochloride Gfh925 More therapies…

    Learn about Your Condition

    Thrombosis prophylaxis Lung adenocarcinoma stage III Fragile X syndrome Major depression Encephalitis Japanese B Transient ischaemic attack Diabetic gastroparesis Pseudomonas infection Gastrectomy Prostate cancer metastatic Kaposi's sarcoma Rectal adenocarcinoma Skin angiosarcoma Foetal growth restriction Osteoarthritis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Malignant melanoma stage III

  • Study of local treatment options for large metastases in patients with BRAF V600 mutated melanoma receiving Encorafenib and Binimetinib combination therapy

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Malignant melanoma stage IV
    • Malignant melanoma stage III
    • Metastatic malignant melanoma
    Investigated Drugs:
    • Binimetinib
    • Encorafenib
    Germany

  • Study on L19IL2 and L19TNF Treatment Before Surgery for Patients with Advanced Melanoma

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Malignant melanoma stage III
    Investigated Drugs:
    • Bifikafusp Alfa
    • Onfekafusp Alfa
    France Germany Italy Poland

  • Study on the Safety of Continued Treatment with GME751 (Pembrolizumab Biosimilar) for Patients with Melanoma or Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Malignant melanoma stage II
    • Malignant melanoma stage III
    • Non-small cell lung cancer
    Investigated Drugs:
    • Pemetrexed Disodium Hemipentahydrate
    • Pembrolizumab
    Lithuania Romania Spain

  • Study of Nivolumab and Relatlimab for Patients with Stage III-IV Melanoma After Surgery

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Malignant melanoma stage IV
    • Malignant melanoma stage III
    Investigated Drugs:
    • Relatlimab
    • Nivolumab
    Austria Belgium Czechia Denmark Finland France +7

  • Study on the Safety and Effects of ATL001 and Nivolumab for Adults with Metastatic or Recurrent Melanoma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Desmoplastic melanoma
    • Malignant melanoma of eyelid
    • Malignant melanoma stage IV
    Investigated Drugs:
    • Atl001
    • Nivolumab
    Spain

  • Study on the Effectiveness and Safety of RO7198457 and Pembrolizumab for Patients with Untreated Advanced Melanoma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Malignant melanoma stage IV
    • Melanoma recurrent
    • Malignant melanoma stage III
    Investigated Drugs:
    • Autogene Cevumeran
    • Pembrolizumab
    Germany Spain
Previous Page
1 2 3
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!